Dr. Mitchell Reed Smith M.D.
Oncologist | Medical Oncology
333 Cottman Ave Fox Chase Cancer Cen Philadelphia PA, 19111About
Dr. Mitchell Smith is an oncologist practicing in Philadelphia, PA. Dr. Smith specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Smith manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes.
- Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance.
- Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine.
- Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma.
- Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.
- Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
- Enhanced efficacy of therapy with antisense BCL-2 oligonucleotides plus anti-CD20 monoclonal antibody in scid mouse/human lymphoma xenografts.
- Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
- Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.
- Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature.
- Bortezomib sensitizes non-Hodgkin's lymphoma cells to apoptosis induced by antibodies to tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors TRAIL-R1 and TRAIL-R2.
- Antibodies and hematologic malignancies.
- Mantle cell lymphoma: advances in biology and therapy.
- Review: lymphomatoid granulomatosis: challenges in diagnosis and treatment.
- Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines.
Clinical Trials
Dr. Mitchell Reed Smith M.D.'s Practice location
WASHINGTON, DC 20037Get Direction
Dr. Mitchell Reed Smith M.D.'s reviews
Write ReviewRecommended Articles
- How Ovarian Cancer 'Previvors' Are Paving the Way
Nancy Crowe is a previvor, but she understands if someone doesn’t know what that means. It’s a relatively new term which arose in 2000 from a challenge posted on FORCE’s website. FORCE stands for Facing Our Risk of Cancer Empowered and was started by Sue Friedman in 1999.Sue says the goal of...
- What Are the Early Signs of Lung Cancer?
Lung cancer allows a five-year survival limit, and that is if the disease has not spread elsewhere in the body. This is all the more reason to be alert to early warnings of cancer’s approach. With early detection, cancer survival ratings improve remarkably.1. Misery and mood swingsCarrying the...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- What OB-GYNs Wish Their Patients Knew about Ovarian Cancer
There are numerous things OB-GYN providers want their patients to know about ovarian cancer.For instance, that it is somewhat rare, but deadly. It ranks 5th in cancer deaths among women. Due primarily to the diagnostic issues noted below, about 70% of women are unfortunately in the most advanced...
- The Unspoken Hardships of Breast Cancer and How to Overcome Them
Receiving a cancer diagnosis can be hard enough, let alone having to deal with the financial burden of treatment. In 2010 in the United States, the cost of treating breast cancer was over $16 billion dollars. By 2020, this number is expected to reach up to $20.5 billion.According to the NCI, the...
- Ovarian Cancer: What Every Young Woman Must Know
Any type of cancer diagnosis can be startling and overwhelming; however, an ovarian cancer diagnosis can be even more upsetting to women and their loved ones because of its high mortality rate. Ovarian cancer, often referred to as the “silent killer”, is known as the 5th most common and...
Nearby Providers
- Dr. Vijay K. Gandhi M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Dr. Jon Glass MD909 Walnut St Philadelphia PA 19107
- Dr. Crystal S. Denlinger M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Eiko Klimant201 West Evergreen Avenue Philadelphia Pennsylvania 19118
- Dr. Shayma Master Kazmi MD1331 E Wyoming Ave Philadelphia PA 19124
- Dr. Sunita Dwivedy Nasta MD3400 Spruce St Philadelphia PA 19104